-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Advocacy

ASH-a-Palooza
Program: Trainee Activities and Services
Session: Blood Drop: ASH Advocacy
Friday, December 6, 2024, 3:20 PM-3:30 PM
Friday, December 6, 2024, 3:40 PM-3:50 PM

Bart L. Scott, MD

Fred Hutchinson Cancer Center, Seattle, WA

Disclosures: Scott: Nektar, Johnson and Johnson: Other: data safety monitoring board; BMS, Celgene, Jazz Pharmaceuticals, and Novartis: Other: Advisory Board; Alexion, Celgene, BMS, and Incyte: Consultancy; Celgene, BMS: Honoraria; BMS, Novartis: Research Funding.